NAFASOLINA

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: NAFASOLINA
Generic name: NAPHAZOLINE HYDROCHLORIDE
Manufacturer: Doral Pharmamedics Inc DBA AG Marin Pharmaceuticals
Product type: HUMAN OTC DRUG
SPL set ID: 30cade3d-208f-8594-e063-6394a90ad2a0
SPL ID: 463c40c9-6e49-e804-e063-6394a90a3db8
Version: 2
Effective date: 2025-12-18
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:38:31

Harmonized routes table
Harmonized routes
NASAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		NAFASOLINA	openfda.brand_name
generic name		NAPHAZOLINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Doral Pharmamedics Inc DBA AG Marin Pharmaceuticals	openfda.manufacturer_name
ndc	package	12539-146-01	openfda.package_ndc
ndc	package	12539-146-02	openfda.package_ndc
ndc	product	12539-146	openfda.product_ndc
ndc11	package	12539014602	derived:openfda.package_ndc
ndc11	package	12539014601	derived:openfda.package_ndc
rxcui		1046602	openfda.rxcui
spl id		463c40c9-6e49-e804-e063-6394a90a3db8	id
spl set id		30cade3d-208f-8594-e063-6394a90ad2a0	set_id
unii		MZ1131787D	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Do not exceed recommended dosage. This product may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge. The use of this container by more than one person may spread infection. Do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen. If symptoms persist, consult a doctor. Do not use this product if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor. Do not use this product in children under 12 years of age because it may cause sedation if swallowed. When using this product avoid contact with the eyes.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.